Candel Therapeutics
Price & Volume
Stats
See more52W Range | $3.78-$13.68 |
Market Cap | $301.6M |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $31,000 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$18.1M |
Diluted EPS | -$1.33 |
News
See moreYahoo Finance • 14 days ago
Candel Therapeutics to Present at the Canaccord Genuity 45th Annual Growth Conference
Yahoo Finance • 20 days ago
Candel Therapeutics Receives EMA Orphan Designation for CAN-2409 for the Treatment of Pancreatic Cancer
Yahoo Finance • last month
Brookline Capital initiates Candel Therapeutics stock with Buy rating, $25 target
About
CEO | Dr. Paul-Peter Tak FOCIS, M.D., Ph.D. |
CFO | Mr. Charles Schoch |
Address | 117 Kendrick Street, Needham, MA, United States, 02494 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 38 |
